切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 99 -104. doi: 10.3877/cma.j.issn.1674-0785.2020.02.005

所属专题: 文献

临床研究

预防性输注新鲜冰冻血浆对胰十二指肠切除术患者的近期疗效观察
张鑫1, 谢凤姣2, 刘云飞1, 肖强胜1,()   
  1. 1. 430013 长沙,中南大学湘雅三医院肝胆胰外科
    2. 100191 广州,南方医科大学第三附属医院普通外科
  • 收稿日期:2019-05-14 出版日期:2020-02-15
  • 通信作者: 肖强胜

Short-term efficacy of prophylactic infusion of fresh frozen plasma in patients undergoing pancreaticoduodenectomy

Xin Zhang1, Fengjiao Xie2, Yunfei Liu1, Qiangsheng Xiao1,()   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, Third Xiangya Hospital, Central South University, Changsha 430011, China
    2. Department of General Surgery, the Third Affiliated Hospital of Southern Medical University, Guangzhou 100191, China
  • Received:2019-05-14 Published:2020-02-15
  • Corresponding author: Qiangsheng Xiao
  • About author:
    Corresponding author: Xiao Qiangsheng, Email:
引用本文:

张鑫, 谢凤姣, 刘云飞, 肖强胜. 预防性输注新鲜冰冻血浆对胰十二指肠切除术患者的近期疗效观察[J/OL]. 中华临床医师杂志(电子版), 2020, 14(02): 99-104.

Xin Zhang, Fengjiao Xie, Yunfei Liu, Qiangsheng Xiao. Short-term efficacy of prophylactic infusion of fresh frozen plasma in patients undergoing pancreaticoduodenectomy[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(02): 99-104.

目的

探讨胰十二指肠切除术患者术后预防性输注新鲜冰冻血浆的临床疗效。

方法

回顾性分析中南大学湘雅三医院2015年1月至2018年12月收治的112例接受十二指肠切除术治疗的胰腺恶性肿瘤患者,根据术后6 h是否预防性输注新鲜冰冻血浆(FFP)分为对照组65例和FFP组47例。比较2组患者术后3 d平均生命体征和凝血指标及患者术后肛门排气时间、首次进流食时间、72 h伤口引流量、术后拔除引流管时间、术后住院天数、围手术期费用和术后并发症发生率。

结果

FFP组患者术后血白蛋白浓度显著高于对照组[(36.7±1.4)g/L vs(33.2±1.0)g/L,t=15.109,P<0.001],术后72 h伤口引流量、术后拔除引流管时间、术后住院天数、围手术期费用、总并发症发生率均小于对照组[(131.1±54.6)ml vs (212.0±67.8)ml,t=-6.749,P<0.001;(6.0±1.3)d vs (9.0±1.6)d,t=-10.81,P<0.001;(14.1±1.8)d vs (18.9±3.6)d,t=-9.334,P<0.001;(89 531.0±7789.4)元vs(105 743.3±7440.8)元,t=-11.16,P<0.001);10.6%(5/47) vs 36.9%(24/65),χ2=9.821,P=0.002]。2组患者术后均未出现围手术期死亡,FFP组患者未出现输血相关并发症。

结论

胰十二指肠切除术患者术后预防性输注FFP,具有使患者术后出血少、恢复快、缩短住院时间、减少住院费用和降低并发症发生率等优点,对患者近期临床效果显著。

Objective

To evaluate the clinical efficacy of postoperative prophylactic infusion of fresh frozen plasma in patients undergoing pancreaticoduodenectomy (PD).

Methods

A retrospective analysis was performed on 112 patients with pancreatic malignancies treated by PD at the Third Xiangya Hospital from January 2015 to February 2018. According to whether postoperative 6 h prophylactic infusion of fresh frozen plasma (FFP) was administered or not, the patients were divided into either a control group (n=65 cases) or on FFP group (n=47 cases). The 3-day average vital signs, coagulation parameters, 72-hour postoperative wound drainage, time to anal exhaust, time to first intake, time to postoperative drainage tube removal, postoperative hospital stay, perioperative cost and surgery were compared between the two groups. The incidence of postoperative complications was also compared.

Results

The serum albumin concentration of patients in the FFP group was significantly higher than that in the control group [(36.7±1.4) g/L vs (33.2±1.0) g/L, t=15.109, P<0.001], while the 72-hour postoperative wound drainage, time to postoperative drainage tube removal time, postoperative hospital stay, perioperative cost, and total complication rate were all smaller than those in the control group [(131.1±54.6) ml vs (212.0 ±67.8) ml, t=-6.749, P<0.001; (6.0±1.3) d vs (9.0±1.6) d, t=-10.81, P<0.001; (14.1±1.8) d vs (18.9±3.6) d, t=-9.334, P<0.001; (89 531.0±7789.4) yuan vs (105 743.3±7440.8) yuan, t=-11.16, P<0.001); 10.6% (5/47) vs 36.9% (24/65), χ2=9.821, P=0.002]. There were no perioperative deaths between in either group. There was no blood transfusion-related complications occurred in the plasma group.

Conclusion

Prophylactic infusion of FFP in patients undergoing PD has the advantages of less postoperative bleeding, faster recovery, shorter hospital stay, reduced hospitalization costs, and reduced incidence of complications.

表1 临床资料在FFP组与对照组胰腺恶性肿瘤患者中的比较
临床资料 FFP组 对照组 统计值 P 临床资料 FFP组 对照组 统计值 P
年龄(岁,±s 64.1±9.3 61.6±9.6 t=1.372 0.173 手术类型[例(%)] ? ? χ2=0.604 0.739
体质量指数(kg/m2±s 21.3±2.1 22.8±2.9 t=-1.152 0.228 ? 腹腔镜手术 17(36.2) 27(41.5) ? ?
性别[例(%)] ? ? χ2=0.024 0.877 ? 机器人手术 7(14.9) 11(16.9) ? ?
? 26(55.3) 35(53.8) ? ? ? 开腹手术 23(48.9) 27(41.5) ? ?
? 21(44.7) 30(46.2) ? ? 病理诊断[例(%)] ? ? χ2=1.116 0.973
术前白蛋白[例(%)] ? ? χ2=0.002 0.964 ? 胆总管下端和壶腹部癌 10(21.3) 13(20) ? ?
? ≤35 g/L 28(59.6) 39(60.0) ? ? ? 导管内乳头状液肿瘤 4(8.5) 4(6.2) ? ?
? >35 g/L 19(40.4) 26(40.0) ? ? ? 神经内分泌肿瘤 4(8.5) 4(6.2) ? ?
CA199[例(%)] ? ? χ2=0.687 0.407 ? 十二指肠乳头癌 11(23.4) 17(26.2) ? ?
? ≤27 U/L 18(38.3) 30(46.2) ? ? ? 胰头导管腺癌 16(34.0) 25(38.5) ? ?
? >27 U/L 29(61.7) 35(53.8) ? ? ? 黏液性囊腺癌 2(4.3) 2(3.1) ? ?
营养状况分级[例(%)] ? ? χ2=0.231 1.000 分化程度[例(%)] ? ? χ2=0.470 0.864
? Ⅰ级 1(2.1) 2(3.1) ? ? ? 9(19.1) 12(18.5) ? ?
? Ⅱ级 37(78.7) 51(78.5) ? ? ? 1(2.1) 3(4.6) ? ?
? Ⅲ级 9(19.1) 12(18.5) ? ? ? 37(78.7) 50(76.9) ? ?
ASA分级[例(%)] ? ? χ2=0.272 0.873 分期[例(%)] ? ? χ2=0.072 0.812
? Ⅰ级 5(10.6) 9(13.8) ? ? ? Ⅰ~Ⅱ期 22(46.9) 31(47.7) ? ?
? Ⅱ级 28(59.6) 38(58.5) ? ? ? Ⅲ~Ⅳ期 25(53.1) 34(52.3) ? ?
? Ⅲ级 14(29.8) 18(27.7) ? ? 术前合并症[例(%)] ? ? χ2=0.093 0.760
是否保脾[例(%)] ? ? χ2=0.001 0.983 ? 32(68.1) 46(70.8) ? ?
? 31(66.0) 43(66.2) ? ? ? 15(31.9) 19(29.2) ? ?
? 16(34.0) 22(33.8) ? ? ? ? ? ? ? ?
表2 FFP组与对照组患者手术情况比较(±s
表3 2组胰十二指肠切除术患者手术后相关指标比较(±s
表4 2组胰十二指肠切除术患者术后3 d生命体征对比(±s
表5 2组胰十二指肠切除术患者术后3 d凝血指标对比(±s
[1]
Pindak D, Tomas M, Dolnik J, et al. Morbidity, mortality and long term survival in patients with vascular resection in pancreatic cancer-single center experience [J]. Neoplasma, 2017, 64(3): 460-463.
[2]
Mierke F, Hempel S, Distler M, et al. Impact of portal vein involvement from pancreatic cancer on metastatic pattern after surgical resection [J]. Ann Surg Oncol, 2016, 23(Suppl 5): 730-736.
[3]
Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw, 2017, 5(8): 1028-1061.
[4]
Shah NL, Intagliata NM, Northup PG, et al. Procoagulant therapeutic in liver disease: a critique and clinical rationale [J]. Nat Rev Gastroenterol Hepatol, 2014, 11(11): 675-682.
[5]
Puetz J. Fresh frozen plasma: the most commonly prescribed hemostatic Agent [J]. J Thromb Haemost, 2013, 11(10): 1794-1799.
[6]
Lu Y, Sun G, Liu X, et al. Plasma transfusion in patients with cirrhosis In China: A Retrospective Multicenter Cohort Study [J]. Transfus Med Rev, 2017, 31(2): 107-112.
[7]
Diringer MN, Zazulia AR. Aneurysmal subarachnoid hemorrhage: strategies for preventing vasospasm in the intensive care unit [J]. Semin Respir Crit Care Med, 2017, 38(6): 760-767.
[8]
Wang M, Cai Y, Li Y, et al. Robotic pancreaticoduodenectomy: single-surgeon Initial experience [J]. Indian J Surg, 2018, 80(1): 42-47.
[9]
Joseph B, Zangbar B, Pandit V, et al. The conjoint effect of reduced crystalloid Administration and decreased damage-control laparotomy use in the development of abdominal compartment syndrome [J]. J Trauma Acute Care Surg, 2014, 76(2): 457-461.
[10]
Campion EM, Pritts TA, Dorlac WC, et al. Implementation of a military-derived damage control resuscitation strategy in a civilian trauma center decreases acute hypoxia in massively transfused patients [J]. 2013, 75(2 Suppl 2): S221-227.
[11]
Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of Variceal haemorrhage in cirrhotic patients [J]. Gut, 2015, 64(11): 1680-1704.
[12]
Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes [J]. Transfusion, 2005, 45(5): 660-666.
[13]
Floyd RA, Schneider JE Jr, Dittmer DP. Methylene blue photoin activation of RNA viruses [J]. Antiviral Res, 2004, 61(3): 141-151.
[14]
Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction [J]. Nephrol Dial Transplant, 2005, 20(9): 1880-1888.
[15]
Chai FY, Jiffre D. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery [J]. Ann Surg, 2011, 254(4): 665.
[16]
Ibarra-Meneses AV, Sanchez C, Alvar J, et al. Monocyte chemotactic protein in plasma from soluble leishmania antigen-stimulated whole blood as a potential biomarker of the cellular immune response to leishmania infantum [J]. Front Immunol, 2017, 8: 1208.
[17]
Cardenas JC, Cap AP, Swartz MD, et al. Plasma resuscitation promotes coagulation homeostasis following shock-induced hypercoagulability [J]. Shock, 2016, 45(2): 166-173.
[18]
Desborough M, Sandu R, Brunskill SJ, et al. Fresh frozen plasma for cardiovascular surgery [J]. Cochrane Database Syst Rev, 2015(7): CD007614.
[19]
Sperry JL, Ochoa JB, Gunn SR, et al. An FFP:PRBC transfusion ratio≥1:1.5 is associated with a lower risk of mortality after massivetransfusion [J]. J Trauma, 2008, 65(5): 986-993.
[20]
Ghazi L, Schwann TA, Engoren MC, et al. Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery [J]. Thromb Res, 2015, 136(6): 1204-1210.
[21]
Kordzadeh A, Askari A, Parsa AD, et al. The Clinical implication of blood product transfusion on morbidity and mortality of ruptured abdominal aortic aneurysm [J]. Clin Appl Thromb Hemost, 2017, 23(6): 601-606.
[22]
Wille T, Thiermann H, Worek F. In vitro kinetics of nerve agent Degradation by fresh frozen plasma (FFP) [J]. Arch Toxicol, 2014, 88(2): 301-307.
[23]
Rouzi AA, Qari MH, Ardawi MS. The use of fresh frozen plasma for reproduction in severe factor V deficiency [J]. Clin Exp Obstet Gynecol, 2015, 42(3): 384-385.
[24]
Deng X, Cao Y, Huby MP, et al. Adiponectin in fresh frozen plasma contributes to restoration of vascular barrier function after hemorrhagic shock [J]. Shock, 2016, 45(1): 50-54.
[25]
Puetz J. Fresh frozen plasma: the most commonly prescribed hemostatic agent [J]. J Thromb Haemost, 2013, 11(10): 1794-1799.
[1] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[2] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[3] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[4] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[5] 史成宇, 季晓琳, 田莉莹, 张来香. 腹腔镜胰十二指肠切除术中第14c/d组淋巴结清扫在胰头癌中的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 430-433.
[6] 杨尹默, 陈依然, 田孝东. 努力提高腹腔镜胰十二指肠切除术的规范化水平[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 237-242.
[7] 张太平, 刘悦泽. 腹腔镜胰十二指肠切除术要点与原则[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 243-245.
[8] 王槐志, 孙丕绛, 崔上. 腹腔镜下胰十二指肠切除术的难点与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 246-248.
[9] 罗柳平, 吴萌萌, 陈欣磊, 林科灿. 胰腺全系膜切除在胰头癌根治术中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 651-656.
[10] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[11] 韩青雷, 丛赟, 李佳隆, 邵英梅. 术前减黄方式对壶腹周围癌胰十二指肠切除术后并发症的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 665-669.
[12] 王天福, 王刚. 自身免疫性胰腺炎诊治现状[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 492-497.
[13] 陈卫波, 朱玉文, 杨豪, 陆泽坤, 邬迪, 祖广晨, 张悦, 陈学敏. 一种改良胰肠吻合方式安全性及其在腹腔镜和开腹胰十二指肠切除术中应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 498-503.
[14] 孟煜凡, 李永政, 樊知遥, 展翰翔. 瘤内微生物在胰腺癌发病和演进中的作用机制及研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 577-582.
[15] 楚海强, 杨远游, 任刚. 胰腺癌放射治疗联合其他治疗方法的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 392-396.
阅读次数
全文


摘要